IFNG and rheumatoid arthritis: Ye et al. [37] utilized the CK2 inhibitor CX4945 to inhibit Th1 and Th17 cell responses while promoting Th2 cell responses in RA, which significantly dampened IFN-γ and IL-17A production and alleviated the inflammatory state.